← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksSEMPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Select Medical Holdings Corporation (SEM) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026

Current Price
$14.97
Market reference
Price Target
$18.00
+20.2% Upside
Target Range
$17.00 — $19.00
High conviction
Analyst Rating
Buy
13 analysts
Forward P/E12.0x
Trailing P/E12.9x
Forward PEG—
Implied Growth+39.6%
Median Target$18.00
Analyst Spread11.1%

Analysts see +20.2% upside to their consensus target of $18.00. The bullish rating consensus aligns with positive price target gap.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$14.97
Consensus$18.00
High$19.00
Low$17.00
Model$8.50
Bear Case
$17
+13.6%
Consensus
$18
+20.2%
Bull Case
$19
+26.9%
Valuation Model TargetsConfidence: 49/100
Bear$7
Base$9
Bull$23

Analyst Ratings Distribution

Breakdown of 13 published analyst recommendations for SEM

46% hold / mixed conviction
+19
BearishBullish
Weighted analyst sentiment score based on 13 ratings
ConsensusBuy
Coverage13 Analysts
Net Score+19
Bull / Bear46% / 8%
Strong Buy00%
Buy646%
Hold646%
Sell18%
Strong Sell00%
Strong Buy
00%
Buy
646%
Hold
646%
Sell
18%
Strong Sell
00%
Recommendation Mix46% Buy · 46% Hold · 8% Sell
Buy (6)Hold (6)Sell (1)

SEM Price Target Analysis

Updated March 3, 2026

As of March 3, 2026, Select Medical Holdings Corporation (SEM) has a Wall Street consensus price target of $18.00, based on estimates from 13 covering analysts. With the stock currently trading at $14.97, this represents a potential upside of +20.2%. The company has a market capitalization of $1.85B.

Analyst price targets range from a low of $17.00 to a high of $19.00, representing a 11% spread in expectations. The median target of $18.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, SEM trades at a trailing P/E of 12.9x and forward P/E of 12.0x. Analysts expect EPS to grow +39.6% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $8.50, with bear and bull scenarios of $6.69 and $22.93 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+13.7%
Avg Forward P/E21.0x
Peers with Coverage6 / 7
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
SEMSelect Medical Holdings Corporation
$1.9B$14.97$18.00+20.2%Buy12.0x13
ENSGThe Ensign Group, Inc.$12.4B$214.17$222.33+3.8%Buy28.5x13
EHCEncompass Health Corporation$10.8B$107.88$151.50+40.4%Buy18.2x26
BKDBrookdale Senior Living Inc.$3.6B$15.30$17.50+14.4%Buy—12
NHCNational HealthCare Corporation$2.5B$163.50———20.5x—
PNTGThe Pennant Group, Inc.$1.2B$33.71$39.00+15.7%Buy25.8x7
SNDASonida Senior Living, Inc.$682M$35.89$31.50-12.2%Hold—2

Upside Potential Comparison

EHC
+40.4%
SEM
+20.2%
PNTG
+15.7%
BKD
+14.4%
ENSG
+3.8%
SNDA
-12.2%

See SEM's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is SEM Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare SEM vs AGIO

See how SEM stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

What is the SEM stock price target for 2026?

The consensus Wall Street price target for SEM is $18, representing 20.2% upside from the current price of $14.97. With 13 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is SEM a buy, sell, or hold?

SEM has a consensus rating of "Buy" based on 13 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $18 implies 20.2% upside from current levels.

Is SEM stock overvalued or undervalued?

With a forward P/E of 12.0367x, SEM trades at a relatively low valuation. The consensus target of $18 implies 20.2% appreciation, suggesting meaningful undervaluation.

How high can SEM stock go?

The most bullish Wall Street analyst has a price target of $19 for SEM, while the most conservative target is $17. The consensus of $18 represents the median expectation. Our quantitative valuation model projects a bull case target of $23 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover SEM stock?

SEM is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the SEM stock forecast?

The 12-month SEM stock forecast based on 13 Wall Street analysts shows a consensus price target of $18, with estimates ranging from $17 (bear case) to $19 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $9, with bear/bull scenarios of $7/$23.

What is SEM's fair value based on fundamentals?

Our quantitative valuation model calculates SEM's fair value at $9 (base case), with a bear case of $7 and bull case of $23. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.

What is SEM's forward P/E ratio?

SEM trades at a forward P/E ratio of 12.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy SEM stock?

Wall Street analysts are very optimistic on SEM, with a "Buy" consensus rating and $18 price target (20.2% upside). 6 of 13 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do SEM price targets vary so much?

SEM analyst price targets range from $17 to $19, a 11% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18 consensus represents the middle ground. Our model's $7-$23 range provides an independent fundamental perspective.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.